Methylene Blue and Lung Cancer
Based on 2018’s Sanchala et al evidence, methylene blue as an Hsp70 inhibitor is a potent and promising anticancer agent.
Based on 2018’s Sanchala et al evidence, methylene blue as an Hsp70 inhibitor is a potent and promising anticancer agent.
The entire narrative of cholesterol being the villain in heart disease was built on a lie.